Ownership and insider activity for LENSAR Inc (LNSR): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Price
| Price | $7.09 |
| Market Cap | $87M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-03 | HAMMER TODD B | A-Award | 17,421 | |
| 2026-06-03 | ELLIS THOMAS B | A-Award | 17,421 | |
| 2026-06-03 | Wong Kendra | A-Award | 13,066 | |
| 2026-06-03 | Connaughton Alan B. | A-Award | 34,843 | |
| 2026-06-03 | CURTIS NICHOLAS T | A-Award | 130,662 | |
| 2026-06-03 | WEISNER AIMEE S | A-Award | 17,421 | |
| 2026-06-03 | O'Farrell Elizabeth G. | A-Award | 17,421 | |
| 2026-06-03 | Winer Gary M | A-Award | 17,421 | |
| 2026-06-03 | LINDSTROM RICHARD L MD | A-Award | 17,421 | |
| 2026-06-03 | LINK WILLIAM J PHD | A-Award | 17,421 |
Balance Sheet (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.3M | $4.6M | $40.6M | $31.6M | $14.7M | $20.6M | $16.3M | $13.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | $3.4M | $6.2M | $5.0M |
| Receivables | $3.3M | $3.9M | $2.5M | $5.0M | $6.2M | $4.3M | $6.5M | $6.4M |
| Inventory | $4.1M | $8.1M | $13.5M | $6.5M | $11.7M | $15.7M | $11.4M | $21.5M |
| Total Current Assets | $11.7M | $17.2M | $58.4M | $44.8M | $33.7M | $46.4M | $42.0M | $46.8M |
| Property, Plant & Equipment | $3.6M | $2.2M | $4.4M | $7.4M | $6.9M | $10.3M | $664000 | $505000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $12.3M | $13.4M | $12.1M | $10.9M | $12.1M | $11.0M | $6.1M | $5.2M |
| Total Assets | $28.9M | $34.5M | $79.1M | $66.5M | $55.8M | $69.6M | $66.3M | $71.4M |
| Accounts Payable | $1.4M | $1.6M | $2.5M | $2.7M | $5.4M | $4.0M | $6.0M | $19.0M |
| Short-term Debt | $653000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $7.7M | $7.8M | $8.5M | $8.7M | $11.4M | $11.6M | $15.0M | $40.6M |
| Long-term Debt | $41.2M | $20.2M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $49.4M | $65.1M | $11.9M | $11.6M | $13.9M | $22.4M | $47.7M | $97.4M |
| Retained Earnings | -$23.5M | -$38.2M | -$58.0M | -$77.6M | -$97.5M | -$111.9M | -$143.3M | -$177.6M |
| Total Equity | -$20.5M | -$30.6M | $67.2M | $54.9M | $42.0M | $47.2M | $18.6M | -$26.0M |
| Total Debt | $41.2M | $20.5M | $3.8M | $3.3M | $2.8M | $2.3M | $2.6M | $2.7M |
| Net Debt | $37.9M | $15.9M | -$36.8M | -$28.3M | -$11.9M | -$21.8M | -$19.8M | -$15.2M |
| Working Capital | $4.1M | $9.4M | $49.9M | $36.1M | $22.3M | $34.8M | $27.0M | $6.2M |
Financial Health
| Debt / Equity | 0.16 |
| Current Ratio | 2.39 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -2.84 |
Profitability
| Return on Equity | 10380.25% |
| Return on Invested Capital | -16.02% |
| Return on Assets | 49.88% |
| Gross Margin | 47.96% |
| Operating Margin | -13.48% |
| Net Margin | 57.57% |
Related companies: ANIK · ARAY · AVR · CRBP · CRDF · MXCT · OWLT
Explore sector: Healthcare · Medical - Devices
More sections of LNSR: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks